DNAJB1-PRKACA fusion peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DNAJB1-PRKACA fusion peptide vaccine, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA [Phase 1]